The Sooner, the Better: The Establishment of a Treatment Paradigm in Prostate Cancer

The Sooner, the Better: The Establishment of a Treatment Paradigm in Prostate Cancer

Bibliographic Details
Main Authors:	Carlo Buonerba, Giuseppe Di Lorenzo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-10-01
Series:	Frontiers in Pharmacology
Subjects:	prostate cancer hormonal therapy overall survival safety chemotherapy
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00788/full

Similar Items

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
by: Benedikt Hoeh, et al.
Published: (2021-11-01)

The analysis of breast cancer survival in East Azerbaijan province of Iran; prognostic impact of chemotherapy and hormone therapy protocols
by: Zohreh Sanaat, et al.
Published: (2022-01-01)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
by: Giuseppe Fallara, et al.
Published: (2023-06-01)

A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data
by: Martina Maggi, et al.
Published: (2021-06-01)

The continuing conundrum in oligometastatic breast carcinoma: A real-world data
by: Gangothri Selvarajan, et al.
Published: (2022-06-01)

Clinical characteristics and survival outcomes in patients with a high PSA and non-metastatic prostate cancer
by: Cheng-Yu Huang, et al.
Published: (2022-01-01)

Changes in Sexuality of Castration-Resistant Prostate Cancer Patients under Hormone Therapy in Japan: A Case Study
by: Yoshiyuki Kashiwagi, et al.
Published: (2016-12-01)

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer
by: Igor Tsaur, et al.
Published: (2021-09-01)

Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients
by: Feng Zhao, et al.
Published: (2019-11-01)

Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis
by: Gianpaolo Perletti, et al.
Published: (2015-07-01)

Establishment of Prognostic Nomograms for Early-Onset Prostate Cancer Patients: A SEER Database Analysis
by: Jingtao Li, et al.
Published: (2022-07-01)

Advancements in the treatment of metastatic hormone-sensitive prostate cancer
by: Hengping Li, et al.
Published: (2022-08-01)

Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer
by: Niraj Shenoy, et al.
Published: (2016-01-01)

Prognostic value of HER2/neu expression in patients with prostate cancer: a systematic review
by: Mozhgan Moghadas niyat
Published: (2015-10-01)

Prognostic value of HER2/neu expression in patients with prostate cancer: a systematic review
by: Mozhgan Moghadas niyat
Published: (2015-09-01)

Genomic and epigenomic alterations in prostate cancer
by: Anna Maria eAschelter, et al.
Published: (2012-11-01)

Pattern of Radiotherapy Treatment in Low-Risk, Intermediate-Risk, and High-Risk Prostate Cancer Patients: Analysis of National Cancer Database
by: Rishabh Agrawal, et al.
Published: (2022-11-01)

PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment
by: Lorenzo Bianchi, et al.
Published: (2023-03-01)

Comparison of doublet and triplet therapies for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis
by: Lei Wang, et al.
Published: (2023-03-01)

Adult primary prostate sarcoma: A multi-center cohort study and comparison between Chinese and American cases
by: Beichen Ding, et al.
Published: (2021-01-01)

Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
by: Natalia I. Samaneva, et al.
Published: (2021-05-01)

Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review
by: Bartosz Malinowski, et al.
Published: (2019-10-01)

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac
by: Jesús A. Junco, et al.
Published: (2019-02-01)

Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy
by: Łukasz Magrowski, et al.
Published: (2022-10-01)

Prophylactic Lymphadenectomy in Patients with Penile Cancer: Is Sooner Better?
by: Tommaso Cai, et al.
Published: (2023-11-01)

Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?
by: Octavio A. Castillo, et al.
Published: (2015-04-01)

A NEW PARADIGM IN TREATMENT OF CHRONIC PROSTATITIS AS PREVENTION OF DEVELOPMENT OF PROSTATIC HYPERPLASIA
by: Y. G. Alyaev, et al.
Published: (2022-12-01)

The Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer Treated With Novel Hormonal Therapy or Chemotherapy: A Systematic Review and Meta-analysis
by: Zhize Wang, et al.
Published: (2020-11-01)

Efficacy of Treatment for Metastatic Hormone-Sensitive Prostate Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses
by: Pokket Sirisreetreerux, et al.
Published: (2023-12-01)

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
by: Jasmine Lim, et al.
Published: (2020-07-01)

The Sooner, the Better
by: Frank Niklas, et al.
Published: (2016-10-01)

The Sooner, The Better
by: Volkmar Falk, MD, et al.
Published: (2021-02-01)

The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer
by: Xie J, et al.
Published: (2023-03-01)

Timing of therapies for Down syndrome: the sooner, the better
by: Fiorenza eStagni, et al.
Published: (2015-10-01)

EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment
by: Gerard Milano, et al.
Published: (2010-07-01)

The Role of Intermittent Chemotherapy in the Survival of Patients with Hormone Refractory Prostate Cancer
by: Jamal Hoseini, et al.
Published: (2011-10-01)

The Role of Intermittent Chemotherapy in the Survival of Patients with Hormone Refractory Prostate Cancer
by: Mozaffar Aznab, et al.
Published: (2011-09-01)

Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives
by: B Ya Alekseev, et al.
Published: (2014-06-01)

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
by: David Thurtle, et al.
Published: (2020-06-01)

Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study
by: Furaha Kariburyo, et al.
Published: (2018-06-01)